Liposomes are a type of nano-sized phospholipid bubbles, which have attracted much attention as potential drug carriers. Liposomes are highly biocompatible and easy to control in vivo and can be loaded with a broad variety of drugs, DNA, and diagnostic agents. To date, a variety of liposomal drugs are under development and some of them are already approved for clinical use.
Market Analysis and Insights: Global Liposome Development Service Market
The global Liposome Development Service market is projected to grow from US$ 1135 million in 2024 to US$ 1807.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period.
Global key players of liposome development service include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, etc. The top two players hold a share over 52%. North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately. In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.
Report Covers:
This report presents an overview of global market for Liposome Development Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Liposome Development Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liposome Development Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Development Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Liposome Development Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liposome Development Service revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Creative Biolabs
Creative Biostructure
T&T Scientific
FormuMax Scientific
PlantaCorp
CD Bioparticles
Segment by Type
Liposomes
Lipid Nanoparticles
Segment by Application
Preclinical
Clinical
Commercial
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liposome Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Development Service companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Development Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Development Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Liposome Development Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Development Service Market Perspective (2019-2030)
2.2 Global Liposome Development Service Growth Trends by Region
2.2.1 Liposome Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liposome Development Service Historic Market Size by Region (2019-2024)
2.2.3 Liposome Development Service Forecasted Market Size by Region (2025-2030)
2.3 Liposome Development Service Market Dynamics
2.3.1 Liposome Development Service Industry Trends
2.3.2 Liposome Development Service Market Drivers
2.3.3 Liposome Development Service Market Challenges
2.3.4 Liposome Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Liposome Development Service by Players
3.1.1 Global Liposome Development Service Revenue by Players (2019-2024)
3.1.2 Global Liposome Development Service Revenue Market Share by Players (2019-2024)
3.2 Global Liposome Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liposome Development Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Liposome Development Service Market Concentration Ratio
3.4.1 Global Liposome Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Development Service Revenue in 2023
3.5 Global Key Players of Liposome Development Service Head office and Area Served
3.6 Global Key Players of Liposome Development Service, Product and Application
3.7 Global Key Players of Liposome Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Development Service Breakdown Data by Type
4.1 Global Liposome Development Service Historic Market Size by Type (2019-2024)
4.2 Global Liposome Development Service Forecasted Market Size by Type (2025-2030)
5 Liposome Development Service Breakdown Data by Application
5.1 Global Liposome Development Service Historic Market Size by Application (2019-2024)
5.2 Global Liposome Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liposome Development Service Market Size (2019-2030)
6.2 North America Liposome Development Service Market Size by Type
6.2.1 North America Liposome Development Service Market Size by Type (2019-2024)
6.2.2 North America Liposome Development Service Market Size by Type (2025-2030)
6.2.3 North America Liposome Development Service Market Share by Type (2019-2030)
6.3 North America Liposome Development Service Market Size by Application
6.3.1 North America Liposome Development Service Market Size by Application (2019-2024)
6.3.2 North America Liposome Development Service Market Size by Application (2025-2030)
6.3.3 North America Liposome Development Service Market Share by Application (2019-2030)
6.4 North America Liposome Development Service Market Size by Country
6.4.1 North America Liposome Development Service Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Liposome Development Service Market Size by Country (2019-2024)
6.4.3 North America Liposome Development Service Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Liposome Development Service Market Size (2019-2030)
7.2 Europe Liposome Development Service Market Size by Type
7.2.1 Europe Liposome Development Service Market Size by Type (2019-2024)
7.2.2 Europe Liposome Development Service Market Size by Type (2025-2030)
7.2.3 Europe Liposome Development Service Market Share by Type (2019-2030)
7.3 Europe Liposome Development Service Market Size by Application
7.3.1 Europe Liposome Development Service Market Size by Application (2019-2024)
7.3.2 Europe Liposome Development Service Market Size by Application (2025-2030)
7.3.3 Europe Liposome Development Service Market Share by Application (2019-2030)
7.4 Europe Liposome Development Service Market Size by Country
7.4.1 Europe Liposome Development Service Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Liposome Development Service Market Size by Country (2019-2024)
7.4.3 Europe Liposome Development Service Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Liposome Development Service Market Size (2019-2030)
8.2 China Liposome Development Service Market Size by Type
8.2.1 China Liposome Development Service Market Size by Type (2019-2024)
8.2.2 China Liposome Development Service Market Size by Type (2025-2030)
8.2.3 China Liposome Development Service Market Share by Type (2019-2030)
8.3 China Liposome Development Service Market Size by Application
8.3.1 China Liposome Development Service Market Size by Application (2019-2024)
8.3.2 China Liposome Development Service Market Size by Application (2025-2030)
8.3.3 China Liposome Development Service Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Liposome Development Service Market Size (2019-2030)
9.2 Asia Liposome Development Service Market Size by Type
9.2.1 Asia Liposome Development Service Market Size by Type (2019-2024)
9.2.2 Asia Liposome Development Service Market Size by Type (2025-2030)
9.2.3 Asia Liposome Development Service Market Share by Type (2019-2030)
9.3 Asia Liposome Development Service Market Size by Application
9.3.1 Asia Liposome Development Service Market Size by Application (2019-2024)
9.3.2 Asia Liposome Development Service Market Size by Application (2025-2030)
9.3.3 Asia Liposome Development Service Market Share by Application (2019-2030)
9.4 Asia Liposome Development Service Market Size by Region
9.4.1 Asia Liposome Development Service Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Liposome Development Service Market Size by Region (2019-2024)
9.4.3 Asia Liposome Development Service Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Liposome Development Service Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Liposome Development Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Liposome Development Service Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Liposome Development Service Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Liposome Development Service Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Liposome Development Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Liposome Development Service Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Liposome Development Service Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Liposome Development Service Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Liposome Development Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Liposome Development Service Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Liposome Development Service Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Liposome Development Service Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Details
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Liposome Development Service Introduction
11.1.4 Precision NanoSystems Revenue in Liposome Development Service Business (2019-2024)
11.1.5 Precision NanoSystems Recent Developments
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Liposome Development Service Introduction
11.2.4 Evonik Revenue in Liposome Development Service Business (2019-2024)
11.2.5 Evonik Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Liposome Development Service Introduction
11.3.4 Merck KGaA Revenue in Liposome Development Service Business (2019-2024)
11.3.5 Merck KGaA Recent Developments
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Details
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Liposome Development Service Introduction
11.4.4 Genevant Sciences Revenue in Liposome Development Service Business (2019-2024)
11.4.5 Genevant Sciences Recent Developments
11.5 Exelead
11.5.1 Exelead Company Details
11.5.2 Exelead Business Overview
11.5.3 Exelead Liposome Development Service Introduction
11.5.4 Exelead Revenue in Liposome Development Service Business (2019-2024)
11.5.5 Exelead Recent Developments
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Details
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Liposome Development Service Introduction
11.6.4 Avanti Polar Lipids Revenue in Liposome Development Service Business (2019-2024)
11.6.5 Avanti Polar Lipids Recent Developments
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Details
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Liposome Development Service Introduction
11.7.4 Nippon Fine Chemical Revenue in Liposome Development Service Business (2019-2024)
11.7.5 Nippon Fine Chemical Recent Developments
11.8 Lipoid
11.8.1 Lipoid Company Details
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Liposome Development Service Introduction
11.8.4 Lipoid Revenue in Liposome Development Service Business (2019-2024)
11.8.5 Lipoid Recent Developments
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Details
11.9.2 Polymun Scientific Business Overview
11.9.3 Polymun Scientific Liposome Development Service Introduction
11.9.4 Polymun Scientific Revenue in Liposome Development Service Business (2019-2024)
11.9.5 Polymun Scientific Recent Developments
11.10 Corden Pharma
11.10.1 Corden Pharma Company Details
11.10.2 Corden Pharma Business Overview
11.10.3 Corden Pharma Liposome Development Service Introduction
11.10.4 Corden Pharma Revenue in Liposome Development Service Business (2019-2024)
11.10.5 Corden Pharma Recent Developments
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Details
11.11.2 Acuitas Therapeutics Business Overview
11.11.3 Acuitas Therapeutics Liposome Development Service Introduction
11.11.4 Acuitas Therapeutics Revenue in Liposome Development Service Business (2019-2024)
11.11.5 Acuitas Therapeutics Recent Developments
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Liposome Development Service Introduction
11.12.4 Creative Biolabs Revenue in Liposome Development Service Business (2019-2024)
11.12.5 Creative Biolabs Recent Developments
11.13 Creative Biostructure
11.13.1 Creative Biostructure Company Details
11.13.2 Creative Biostructure Business Overview
11.13.3 Creative Biostructure Liposome Development Service Introduction
11.13.4 Creative Biostructure Revenue in Liposome Development Service Business (2019-2024)
11.13.5 Creative Biostructure Recent Developments
11.14 T&T Scientific
11.14.1 T&T Scientific Company Details
11.14.2 T&T Scientific Business Overview
11.14.3 T&T Scientific Liposome Development Service Introduction
11.14.4 T&T Scientific Revenue in Liposome Development Service Business (2019-2024)
11.14.5 T&T Scientific Recent Developments
11.15 FormuMax Scientific
11.15.1 FormuMax Scientific Company Details
11.15.2 FormuMax Scientific Business Overview
11.15.3 FormuMax Scientific Liposome Development Service Introduction
11.15.4 FormuMax Scientific Revenue in Liposome Development Service Business (2019-2024)
11.15.5 FormuMax Scientific Recent Developments
11.16 PlantaCorp
11.16.1 PlantaCorp Company Details
11.16.2 PlantaCorp Business Overview
11.16.3 PlantaCorp Liposome Development Service Introduction
11.16.4 PlantaCorp Revenue in Liposome Development Service Business (2019-2024)
11.16.5 PlantaCorp Recent Developments
11.17 CD Bioparticles
11.17.1 CD Bioparticles Company Details
11.17.2 CD Bioparticles Business Overview
11.17.3 CD Bioparticles Liposome Development Service Introduction
11.17.4 CD Bioparticles Revenue in Liposome Development Service Business (2019-2024)
11.17.5 CD Bioparticles Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Creative Biolabs
Creative Biostructure
T&T Scientific
FormuMax Scientific
PlantaCorp
CD Bioparticles
听
听
*If Applicable.
